Chiba, Japan

Kazuo Suzuki


 

Average Co-Inventor Count = 1.3

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2011-2025

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Kazuo Suzuki: Innovator in Therapeutic Agents

Introduction

Kazuo Suzuki is a prominent inventor based in Chiba, Japan, known for his significant contributions to the field of therapeutic agents. With a total of eight patents to his name, he has focused on developing innovative solutions for infectious and inflammatory diseases.

Latest Patents

Among his latest patents, Suzuki has introduced a prophylactic and/or therapeutic agent specifically targeting infectious and inflammatory diseases. This invention aims to provide a specialized therapeutic method for conditions such as intractable vasculitis by determining a target molecule that is useful for treatment. The active ingredient in this agent is an antibody that recognizes apolipoprotein A2 (APOA2). Additionally, he has developed an artificial polyclonal immunoglobulin preparation that boasts high therapeutic efficacy and safety, capable of stable supply in large quantities. This composition includes 204 polypeptides represented by specific amino acid sequences, each comprising different heavy chain variable regions.

Career Highlights

Kazuo Suzuki has had a notable career, working with reputable organizations such as Oki Data Infotech Corporation and Chiba University. His work has significantly impacted the development of therapeutic methods and immunoglobulin preparations.

Collaborations

Some of his notable coworkers include Yosuke Kameoka and Yoshio Yamakawa, who have collaborated with him on various projects.

Conclusion

Kazuo Suzuki's innovative work in therapeutic agents showcases his dedication to addressing complex medical challenges. His contributions continue to influence the field of medicine and improve treatment options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…